NCT00001337 2025-06-22Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's LymphomaNational Institutes of Health Clinical Center (CC)Phase 2 Completed348 enrolled 15 charts